Post-thrombotic social impact

Post-thrombotic syndrome Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Post-thrombotic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Social Impact

Case Studies

Case #1

Post-thrombotic social impact On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Post-thrombotic social impact

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Post-thrombotic social impact

CDC on Post-thrombotic social impact

Post-thrombotic social impact in the news

Blogs on Post-thrombotic social impact

Directions to Hospitals Treating Post-thrombotic syndrome

Risk calculators and risk factors for Post-thrombotic social impact

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

## Overview[edit | edit source]

## Socioeconomic Impact of PTS[edit | edit source]

PTS lowers patients’ quality of life after DVT, specifically with regards to physical and psychological symptoms and limitations in daily activities.[1][2][3] Secondly, the treatment of PTS adds significantly to the cost of treating DVT. The annual health care cost of PTS in the United States has been estimated at $200 million, with costs over $3800 per patient in the first year alone, and increasing with disease severity. PTS also causes lost work productivity: patients with severe PTS and venous ulcers lose up to 2 million work days per year.[4]

## References[edit | edit source]

1. ↑ Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 2002;162:1144-8.
2. ↑ Kahn SR, M'Lan CE, Lamping DL, Kurz X, Berard A, Abenhaim L. The influence of venous thromboembolism on quality of life and severity of chronic venous disease. J Thromb Haemost 2004;2:2146-51.
3. ↑ Kahn SR, Shbaklo H, Lamping DL, Holcroft CA, Shrier I, Miron MJ, et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost. 2008;6:1105-12.
4. ↑ Bergqvist D, Jendteg S, Johansen L, Persson U, Odegaard K. Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden. Ann Intern Med 1997;126:454-7.